Dyadic's dyai-100 covid-19 vaccine study published in a leading peer-reviewed scientific journal

“thermophilic filamentous fungus c1-cell-cloned sars-cov-2-spike-rbd-subunit-vaccine adjuvanted with aldydrogel®85 protects k18-hace2 mice against lethal virus challenge”

DYAI Ratings Summary

DYAI Quant Ranking